Safety and Tolerability Study of AZD7762 in Combination With Gemcitabine

Clinical trial NCT00937664 · TERMINATED

Trial details

NCT number: NCT00937664
Sponsor: AstraZeneca
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Cancer Solid Tumors Advanced Solid Malignancies

Start date: 2009-07-01
Primary completion: 2011-02-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.